Skip to main content
. Author manuscript; available in PMC: 2014 Aug 11.
Published in final edited form as: Schizophr Res. 2010 Aug 17;123(1):64–67. doi: 10.1016/j.schres.2010.07.029

Table 1.

Demographic, Diagnosis, Medication Information, and Number of EDA Tests

SZ = Schizophrenia diagnosis

SZAFF = Schizoaffective diagnosis

Participant Number Gender Diagnosis Age at Entry Number of Tests Completed Medication Pre-Remission Medication Pre-Relapse
1 Male SZ 21.8 24 risperidone 2.0 mg/day risperidone 2.0 mg/day
2 Female SZ 25.4 49 risperidone 4.5 mg/day risperidone 4.5 mg/day
3 Male SZ 22.8 58 risperidone 6.0 mg/day risperidone 7.5 mg/day
4 Male SZ 38.0 72 olanzapine 10.0 mg/day olanzapine 10.0 mg/day
5 Male SZ 41.0 30 fluphenazine 10.0 mg/day fluphenazine 9.0 mg/day
6 Female SZAFF 41.3 43 olanzapine 10.0 mg/day fluphenazine 6.25 mg/day olanzapine 50.0 mg/day fluphenazine 10.0 mg/day